Gland Pharma Ltd (GLAND) Stock Price & News

GLAND:NSE

Gland Pharma Ltd

3 340,00 INR

+0,95%

(+31,30) 1D

13-ноя., 15:30:00 GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for GLAND...

Open

3 339,70 INR

High

3 355,00 INR

Low

3 307,20 INR

Mkt. cap

548,61 млд

Avg. vol.

483,48 миң

Volume

207,36 миң

Dividend

0,60%

Quarterly dividend

5,00 INR

Ex-dividend date

2026-ж., 11-авг.

P/E ratio

44,62

52-wk high

3 374,00 INR

52-wk low

1 573,60 INR

EPS

74,86 INR

No. of employees

4 миң

Open

3 339,70 INR

High

3 355,00 INR

Low

3 307,20 INR

Mkt. cap

548,61 млд

Avg. vol.

483,48 миң

Volume

207,36 миң

Dividend

0,60%

Quarterly dividend

5,00 INR

Ex-dividend date

2026-ж., 11-авг.

P/E ratio

44,62

52-wk high

3 374,00 INR

52-wk low

1 573,60 INR

EPS

74,86 INR

No. of employees

4 миң

Related stocks

Dr Reddy's Laboratories Ltd

1 380,00 INR

-0,48%

DIVISLAB

Divi's Laboratories Ltd

11 442,00 INR

-0,37%

IPCALAB

IPCA Laboratories Ltd

1 889,90 INR

-0,52%

News stories

From web sources and news partners

TradingKey

8 саат мурун

S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months

Foreign Policy Journal

7 саат мурун

Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade

The Motley Fool

18 саат мурун

Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years

TradingView

15 саат мурун

EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected

About Gland Pharma Ltd

CEOShyamakant Giri

Employees4,33 миң

Founded1978

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websiteglandpharma.com

All values in INR	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.	2026-ж. сен.
Revenue	16,95 млд	17,43 млд	18,00 млд	19,03 млд
Cost of goods sold	6,31 млд	8,32 млд	6,80 млд	7,30 млд
Cost of revenue	6,31 млд	8,32 млд	6,80 млд	7,30 млд
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4,24 млд	4,26 млд	4,44 млд	4,12 млд
Operating expense	7,37 млд	5,22 млд	7,42 млд	7,35 млд
Total operating expenses	13,68 млд	13,54 млд	14,22 млд	14,65 млд
Operating income	3,27 млд	3,89 млд	3,78 млд	4,38 млд
Other non operating income	631,73 млн	-1,79 млд	612,28 млн	-
EBT including unusual items	3,62 млд	5,06 млд	4,35 млд	4,31 млд
EBT excluding unusual items	3,86 млд	5,02 млд	4,35 млд	4,31 млд
Income tax expense	1,01 млд	1,39 млд	1,18 млд	1,40 млд
Effective tax rate	27,79%	27,51%	27,13%	32,53%
Other operating expenses	2,06 млд	-130,22 млн	1,87 млд	2,08 млд
Net income	2,61 млд	3,67 млд	3,17 млд	2,91 млд
Net profit margin	15,42%	21,04%	17,61%	15,28%
Earnings per share	16,98	22,23	19,22	17,62
Interest and investment income	-	2,06 млд	-	-
Interest expense	-39,30 млн	-63,09 млн	-43,61 млн	-71,38 млн
Net interest expenses	-39,30 млн	1,99 млд	-43,61 млн	-71,38 млн
Depreciation and amortization charges	1,08 млд	1,09 млд	1,11 млд	1,15 млд
EBITDA	4,17 млд	4,91 млд	4,80 млд	5,51 млд
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything